Skip to main content

CHANGE IN RATINGS

Ford Motor

(F) - Get Ford Motor Company Report

downgraded at Bear: Rating on F was lowered to Peer Perform, Bear Stearns said. Positive catalysts have already emerged, and earnings could be soft the next two quarters.

General Motors

(GM) - Get General Motors Company Report

upgraded at Bear: GM was upgraded to Peer Perform, Bear Stearns said. Best restructuring news is already priced into the stock, but outside support from Tracinda should help keep the valuation up.

Gen-Probe

(GPRO) - Get GoPro, Inc. Class A Report

upgraded at Baird: GPRO was upgraded from Neutral to Outperform, Robert Baird said. $55 price target. UNH switching over to LH could be a chance for the company to gain market share.

Intersil

(ISIL)

downgraded at Piper: Piper said it is downgrading ISIL to a Market Perform rating due to uncertainty surrounding PC and related markets.

Questar

(STR)

initiated at Morgan Stanley:Morgan Stanley initiates coverage of Questar with an equal-weight rating and $87 price target.

Symantec

TheStreet Recommends

(SYMC) - Get Symantec Corporation Report

downgraded at Friedman, Billings: SYMC was downgraded from Outperform to Market Perform, Friedman, Billings Ramsey said. Stock is up 40% since mid-July, and trading above the $21 price target. Channel checks do not suggest that earnings upside potential this quarter is likely.

Tivo

(TIVO) - Get TiVo Corp. Report

downgraded at Bear: TIVO was downgraded to Underperform, Bear Stearns said. Appellate court ruled in favor of DISH yesterday, and near-term catalysts could continue to be neutral/negative.

Tyson Foods

(TSN) - Get Tyson Foods, Inc. Class A Report

downgraded at JP Morgan: TSN was downgraded from Overweight to Neutral, JP Morgan said. Estimates also cut, as all of the company's divisions are struggling, except for chicken.

STOCK COMMENTS / EPS CHANGES

Baxter

(BAX) - Get Baxter International Inc. Report

price target increased at Goldman: BAX target upped to $50 from $47 on sale of Transfusion Therapies business, Goldman said. See operating margin expansion due to paring of slow-growing business. Maintained Buy rating.

Boyd Gaming

(BYD) - Get Boyd Gaming Corporation Report

target raised at Jefferies: Jefferies said it is increasing its price target on BYD to $58 from $56.50 after company announced agreement with Harrah's to trade Barbary Coast for about 24 acres on Las Vegas Strip. Maintained Buy rating.

Quest Diagnostics

(DGX) - Get Quest Diagnostics Incorporated Report

price target cut at Jefferies: Jefferies said it is lowering its target on DGX to $55 from $65 due to loss of UNH contract. Noted that 18% selloff seems unwarranted. Reiterated Hold rating.

FactSet

(FDS) - Get FactSet Research Systems Inc. Report

estimates raised at Morgan Stanley: Morgan Stanley is raising 2007-2008 EPS estimates to reflect an increase in the company's organic growth assumptions. Maintain equal-weight rating.

Helix Energy

(HLX) - Get Helix Energy Solutions Group, Inc. Report

price target lowered at Jefferies:HLX target lowered to $58 from $53, Jefferies said. 2006 estimates cut to $3.00 from $3.47 after management lowered guidance. Reiterated Buy rating.

Healthways

(HWAY)

price target cut at Goldman Goldman said it is decreasing its target on HWAY to $38 from $42 after company preannounced positive Q4 numbers with disappointing first-year results in 3-year Medicare Health support pilot program. Maintained Sell rating.

Laboratory Corp (LH) - Get Laboratory Corporation of America Holdings Report

price target raised at Jefferies: Price target on LH increased to $72 from $61, Jefferies said. UNH contract looks attractive, but execution risk remains, along with already expensive valuation. Reiterated Hold rating.

MetLife (MET) - Get MetLife, Inc. Report

estimates raised at Goldman: ldman said it is increasing its 2006 estimates by 5 cents to $4.95 due to low catastrophe losses in Auto and Home division. Price target increased to $62 from $59. Maintain Buy rating.

Mosaic

(MOS) - Get Mosaic Company Report

estimates cut at Goldman: 2007 estimates on MOS lowered to $0.90 from $1.20, Goldman said. Company reported weak Q1 revenues on low phosphate volumes and decreased potash prices. Price target down to $17 from $18 and maintained Neutral rating.